Applied Nutritionals, LLC announces its strategic alliance with Wound Care Innovations, LLC of Fort Lauderdale, Florida, to exclusively distribute its patented hydrolyzed collagen wound care products (marketed as Cellerate_RX^®) into the domestic medical, retail, government and first aid human use wound care markets, as well as most international territories.

Cellerate_RX^® gel and powder are indicated for chronic and acute wounds and skin ulcers, including: pressure ulcers (stages I-IV), venous stasis ulcers, diabetic ulcers, arterial ulcers, surgical wounds, traumatic wounds, first & second degree burns and superficial wounds.

Anita M. Petito, President of Applied Nutritionals, LLC states, "We are excited to be working with Wound Care Innovations, LLC to bring cutting-edge products to the mass markets. The collagen we created is not only cost-effective but helps to reduce pain at the wound site, aiding in patient comfort. Many practitioners claim they achieve rapid wound closure even when other "advanced" modalities have failed. It is very rewarding to know that we are able to help people, especially those who have had open wounds for years."

Applied Nutritionals, LLC having its corporate offices in Bethlehem, PA and its manufacturing facilities in Philadelphia, PA, is recognized as having technologically advanced wound care products featuring a patented molecular form of collagen. The company also specializes in developing unique nutritional supplements which contain the proprietary form of collagen as a key ingredient positioned for wound care and joint support.